Beta Bionics Inc.

NASDAQ: BBNX · Real-Time Price · USD
17.04
0.33 (1.97%)
At close: Aug 15, 2025, 3:59 PM
17.04
0.03%
After-hours: Aug 15, 2025, 05:33 PM EDT

Beta Bionics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q1 2024 Q4 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Mar 31, 2024 Dec 31, 2023
Cash & Equivalents
35.08M 42.45M 30.43M 17.48M n/a 26.57M
Short-Term Investments
214.65M 189.02M 73.14M 43.42M n/a 70.18M
Long-Term Investments
31.15M 64M n/a n/a n/a n/a
Other Long-Term Assets
244K 246K 5.3M 3.35M n/a 221K
Receivables
11.39M 11.01M 12M 7.46M n/a 4.45M
Inventory
17.32M 15.73M 13.32M 11.29M n/a 1.25M
Other Current Assets
7.64M 260K 1.05M 305K -96.75M 275K
Total Current Assets
286.07M 261.92M 132.92M 82.56M n/a 103.62M
Property-Plant & Equipment
12.5M 11.86M 11.42M 11.04M n/a 6.2M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
43.9M 76.11M 16.72M 14.38M n/a 6.42M
Total Assets
329.97M 338.02M 149.65M 96.94M n/a 110.04M
Account Payables
3.42M 3.45M 2.85M 2.85M n/a 1.17M
Deferred Revenue
1.14M 949K 939K n/a n/a n/a
Short-Term Debt
1.52M 1.52M 1.53M 1.45M n/a n/a
Other Current Liabilities
5.78M 4.92M 9.41M 672K n/a 1.14M
Total Current Liabilities
19.49M 16.49M 21.15M 17.88M n/a 10.61M
Long-Term Debt
5.17M n/a n/a n/a n/a n/a
Other Long-Term Liabilities
3.68M 2.33M 44.9M 38.88M -58.61M 37.83M
Total Long-Term Liabilities
8.85M 7.78M 52.48M 46.19M -58.61M 40.83M
Total Liabilities
28.34M 24.27M 73.63M 64.07M -58.61M 51.43M
Total Debt
6.69M 6.97M 7.25M 7.3M n/a 4.22M
Common Stock
4K 4K 1K 1K n/a 1K
Retained Earnings
-342.26M -325.39M -296.74M -278.63M n/a -229.66M
Comprehensive Income
149K 240K 65K 58K -203.1M 137K
Shareholders Equity
301.63M 313.75M 76.01M 32.87M 58.61M 58.61M
Total Investments
245.79M 253.02M 73.14M 43.42M n/a 70.18M